Streetbeat News

Products Services

ARKK

BEN

BITW

BLK

FDX

GBTC

IVZ

VAN

SEC Chair Gary Gensler did not participate in the decision to approve the first-ever spot Ethereum ETFs in the U.S. The SEC’s Trading and Markets Division approved the forms for several spot Ethereum ETFs from companies like BlackRock, Fidelity, and Grayscale. This decision was made under delegated authority, unlike the approval process for spot Bitcoin ETFs, which involved a vote by the commissioners.

Portfolio Pulse from Aniket Verma

May 24, 2024 | 6:40 am

GH

Guardant Health's Shield blood test for colorectal cancer screening has received a strong recommendation from the FDA advisory committee, paving the way for potential FDA approval. This test offers a convenient, non-invasive screening option and is on track to become the first FDA-approved blood test meeting Medicare coverage requirements.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2024 | 6:37 am

MU

NVDA

Nvidia's evaluation has revealed heat and power consumption issues in Samsung's HBM3 and upcoming HBM3E chips, impacting Samsung's AI chip efforts. This has raised concerns about Samsung's competitiveness against SK Hynix and Micron Technology, who continue to supply Nvidia with HBM chips.

Portfolio Pulse from Benzinga Neuro

May 24, 2024 | 6:31 am

GOOG

GOOGL

Google's new AI Overviews feature, part of its Search Generative Experience, has faced backlash for providing inaccurate and sometimes absurd responses. Notable errors include suggesting glue to keep cheese on pizza and incorrectly stating that Barack Obama was the first Muslim President of the U.S. Google has acknowledged these issues and is working to improve the product.

Portfolio Pulse from Ananya Gairola

May 24, 2024 | 6:13 am

NVDA

Nvidia has reduced the prices of its H20 AI chips in China by over 10% to compete with Huawei's Ascend 910B amid increased competition and U.S. sanctions. This move highlights the challenges Nvidia faces in the Chinese market, which contributed 17% of its revenue for fiscal 2024. Despite these challenges, Nvidia continues to adapt its strategy to maintain its presence in China.

Portfolio Pulse from Benzinga Neuro

May 24, 2024 | 6:03 am

HCM

HUTCHMED will present new and updated data from several studies at ASCO 2024, including a Phase II study of fruquintinib combined with sintilimab in endometrial cancer patients. The study showed significant efficacy improvements and a manageable safety profile, supporting a New Drug Application in China.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2024 | 5:51 am

ANL

Adlai Nortye will present encouraging preliminary data on the combination of AN0025 and definitive chemoradiotherapy (dCRT) for esophageal cancer at the ASCO 2024 Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2024 | 5:42 am

AZUL

GOL

Azul and GOL have announced a codeshare agreement to enhance Brazil's domestic flight connectivity, offering access to over 150 destinations and allowing customers to choose their preferred loyalty program for accumulating points.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2024 | 5:39 am

BTCUSD

DOGEUSD

ETHUSD

The Winnie the Pooh-themed cryptocurrency, POOH, surged 46% in the last 24 hours, driven by a proposal to burn 13 Ether worth of POOH. This comes amid sluggish performance from major cryptocurrencies like Bitcoin, Ethereum, and Dogecoin.

Portfolio Pulse from Aniket Verma

May 24, 2024 | 5:28 am

AMD

ARM

ASML

GOOGL

META

MU

NVDA

QQQ

SOXX

SPY

TSM

Nvidia's remarkable turnaround is set to benefit other industry players like Google, Meta, TSM, and ASML, according to Gene Munster. Nvidia's business surged by 216%, and Munster forecasts significant market dynamics shifts driven by AI advancements. Nvidia's stock is up 115.49% year-to-date, outperforming major ETFs.

Portfolio Pulse from Kaustubh Bagalkote

May 24, 2024 | 5:13 am